Clinical trial
Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma
NCT00314873 · Indiana University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00314873 |
|---|---|
| Title | Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma |
| Official title | Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma |
| Lead sponsor | Indiana University School of Medicine, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Thymic Carcinoma |
| Intervention type | Drug |
| Interventions | Gleevec (imatinib) |
| Enrollment | 11 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Apr 17, 2006 |
| Last update posted | Jun 3, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: